Sobolewska Bianka, Utebey Eray, Bartz-Schmidt Karl Ulrich, Tatar Olcay
1 Centre for Ophthalmology, Eberhard-Karls University Tuebingen , Tuebingen, Germany .
J Ocul Pharmacol Ther. 2014 Sep;30(7):567-72. doi: 10.1089/jop.2013.0135. Epub 2014 May 12.
To investigate the long-term functional outcome and its predictive factors of treatment of acute submacular hemorrhage secondary to age-related macular degeneration with intravitreal application of recombinant tissue plasminogen activator (rt-PA) and gas.
Twenty-six patients were enrolled in the retrospective case series. A complete history and ocular examination, including fluorescein angiography, were performed. The best-corrected visual acuity was measured with a Snellen chart. Patients were followed up for 12 to 131 months (mean: 49 months). All patients underwent intravitreal injection of rt-PA (50 μg) and expansile gas. Primary outcome measures were best postoperative and final visual acuity and degree of blood displacement.
The size of the subretinal hemorrhage ranged from 0.5 to 28 disc diameters, and the degree of blood displacement was defined as complete (≥1 disc area from the center of the fovea), partial, or no displacement. Twenty-one (81%) patients showed partial or complete displacement of hemorrhage. Due to lack of displacement of hemorrhage in 5 patients (19%), submacular surgery was performed. In 13 of 21 (62%; P=0.0001) patients with displacement of hemorrhage, the best postoperative visual acuity improved ≥2 lines. The final visual acuity improved ≥2 lines in 42.9% (9 of 21), was stable in 23.8% (5 of 21), and worse ≥2 lines in 33.3% (7 of 21) of patients. The short duration of hemorrhage (≤4 days) and complete displacement of blood, independent of the hemorrhage size, were significantly associated with better postoperative visual acuity (P=0.0001, P=0.0001, respectively).
Intravitreal injection of rt-PA and gas seem to be more effective when applied within the first 4 days of acute submacular hemorrhage. Preoperative visual acuity as well as displacement of hemorrhage might be useful to predict final visual acuity.
探讨玻璃体腔内注射重组组织型纤溶酶原激活剂(rt-PA)联合气体治疗年龄相关性黄斑变性继发急性黄斑下出血的长期功能结局及其预测因素。
本回顾性病例系列纳入了26例患者。进行了完整的病史和眼部检查,包括荧光素血管造影。用Snellen视力表测量最佳矫正视力。患者随访12至131个月(平均:49个月)。所有患者均接受了玻璃体腔内注射rt-PA(50μg)和膨胀性气体。主要结局指标为术后最佳视力和最终视力以及血液清除程度。
视网膜下出血大小范围为0.5至28个视盘直径,血液清除程度定义为完全清除(距黄斑中心≥1个视盘面积)、部分清除或未清除。21例(81%)患者出现了部分或完全的出血清除。由于5例(19%)患者出血未清除,因此进行了黄斑下手术。在21例有出血清除的患者中,13例(62%;P=0.0001)术后最佳视力提高了≥2行。最终视力提高≥2行的患者占42.9%(21例中的9例),视力稳定的患者占23.8%(21例中的5例),视力下降≥2行的患者占33.3%(21例中的7例)。出血持续时间短(≤4天)和血液完全清除,与出血大小无关,均与术后更好的视力显著相关(分别为P=0.0001,P=0.0001)。
急性黄斑下出血发生的前4天内玻璃体腔内注射rt-PA联合气体似乎更有效。术前视力以及出血清除情况可能有助于预测最终视力。